SCHEMBL10077797

SCHEMBL10077797

CCOC(=O)C1=CC(OCCN(CCC(=O)OC(C)(C)C)S(=O)(=O)c2ccccc2[N+](=O)[O-])=CC(C(=O)OCC)N1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.35
NR1D1 P20393 2/20 0.33
KMT2A Q03164 4/20 0.32
ALDH1A1 P00352 3/20 0.32
MAPK1 P28482 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
MEN1 O00255 3/20 0.32
USP2 O75604 1/20 0.32
MET P08581 1/20 0.31
MAPT P10636 2/20 0.31
PTPN1 P18031 2/20 0.31
CACNA1D Q01668 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30
ADORA3 P0DMS8 1/20 0.30
OPRM1 P35372 1/20 0.30
OPRD1 P41143 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL526531 0.77 NR1D1 (0.38) HIF1ANR1D1KMT2AALDH1A1MAPK1
SCHEMBL10077084 0.74 ALDH1A1 (0.39) KMT2AALDH1A1MAPK1TDP1MEN1
SCHEMBL530068 0.73 NR1D1 (0.43) NR1D1KMT2ATDP1MEN1MET
SCHEMBL18900250 0.73 NR1D1 (0.35) HIF1ANR1D1KMT2AALDH1A1MAPK1
SCHEMBL530360 0.73 NR1D1 (0.46) NR1D1KMT2AALDH1A1TDP1MEN1
SCHEMBL10076735 0.73 NR1D1 (0.42) NR1D1KMT2ATDP1MEN1MET
SCHEMBL10076958 0.71 TDP1 (0.36) KMT2AALDH1A1MAPK1TDP1MEN1
SCHEMBL530308 0.71 NR1D1 (0.40) NR1D1KMT2AALDH1A1MEN1MET
SCHEMBL530309 0.69 NR1D1 (0.37) NR1D1KMT2AALDH1A1TDP1MEN1
SCHEMBL17089907 0.69 NR1D1 (0.42) NR1D1KMT2AALDH1A1TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012014147-A1 ANTICANCER DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-02-02 WO disclosed